eMedicine Specialties > Radiology > Chest

Lung Cancer, Non-Small Cell: Multimedia

Author: Sat Sharma, MD, FRCPC, Professor and Head, Division of Pulmonary Medicine, Department of Internal Medicine, University of Manitoba; Site Director, Respiratory Medicine, St Boniface General Hospital
Coauthor(s): Bruce Maycher, MD, Director of Pulmonary Radiology, St Boniface General Hospital; Associate Professor, Department of Radiology, University of Manitoba
Contributor Information and Disclosures

Updated: May 31, 2009

Multimedia

Non–small cell lung cancer. Bronchoscopy. ...
(Enlarge Image)
Media file 1: Non–small cell lung cancer. Bronchoscopy. A large central lesion was diagnosed as non–small cell carcinoma.
[ CLOSE WINDOW ]
Non–small cell lung cancer. Bronchoscopy. ...

Non–small cell lung cancer. Bronchoscopy. A large central lesion was diagnosed as non–small cell carcinoma.

Non–small cell lung cancer. Left pleural ef...
(Enlarge Image)
Media file 2: Non–small cell lung cancer. Left pleural effusion and volume loss secondary to non–small cell carcinoma of the left lower lobe. The pleural effusion was sampled and found to be malignant; therefore, the lesion is inoperable.
[ CLOSE WINDOW ]
Non–small cell lung cancer. Left pleural ef...

Non–small cell lung cancer. Left pleural effusion and volume loss secondary to non–small cell carcinoma of the left lower lobe. The pleural effusion was sampled and found to be malignant; therefore, the lesion is inoperable.

Non–small cell lung cancer. Left upper coll...
(Enlarge Image)
Media file 3: Non–small cell lung cancer. Left upper collapse is almost always secondary to endobronchial bronchogenic carcinoma.
[ CLOSE WINDOW ]
Non–small cell lung cancer. Left upper coll...

Non–small cell lung cancer. Left upper collapse is almost always secondary to endobronchial bronchogenic carcinoma.

Non–small cell lung cancer. Complete left l...
(Enlarge Image)
Media file 4: Non–small cell lung cancer. Complete left lung collapse secondary to bronchogenic carcinoma of left mainstem bronchus.
[ CLOSE WINDOW ]
Non–small cell lung cancer. Complete left l...

Non–small cell lung cancer. Complete left lung collapse secondary to bronchogenic carcinoma of left mainstem bronchus.

Non–small cell lung cancer. A cavitating ri...
(Enlarge Image)
Media file 5: Non–small cell lung cancer. A cavitating right lower lobe squamous cell carcinoma.
[ CLOSE WINDOW ]
Non–small cell lung cancer. A cavitating ri...

Non–small cell lung cancer. A cavitating right lower lobe squamous cell carcinoma.

Non–small cell lung cancer. CT scan shows c...
(Enlarge Image)
Media file 6: Non–small cell lung cancer. CT scan shows cavitation and air-fluid level.
[ CLOSE WINDOW ]
Non–small cell lung cancer. CT scan shows c...

Non–small cell lung cancer. CT scan shows cavitation and air-fluid level.

Non–small cell lung cancer. Patient has rig...
(Enlarge Image)
Media file 7: Non–small cell lung cancer. Patient has right lower lobe opacity. This is not well circumscribed and was found to be a squamous cell carcinoma.
[ CLOSE WINDOW ]
Non–small cell lung cancer. Patient has rig...

Non–small cell lung cancer. Patient has right lower lobe opacity. This is not well circumscribed and was found to be a squamous cell carcinoma.

Non–small cell lung cancer. Right upper lob...
(Enlarge Image)
Media file 8: Non–small cell lung cancer. Right upper lobe lesion diagnosed as adenocarcinoma on percutaneous biopsy.
[ CLOSE WINDOW ]
Non–small cell lung cancer. Right upper lob...

Non–small cell lung cancer. Right upper lobe lesion diagnosed as adenocarcinoma on percutaneous biopsy.

Non–small cell lung cancer. Right upper lob...
(Enlarge Image)
Media file 9: Non–small cell lung cancer. Right upper lobe collapse with the S sign of Golden secondary to underlying non–small cell carcinoma of the bronchus.
[ CLOSE WINDOW ]
Non–small cell lung cancer. Right upper lob...

Non–small cell lung cancer. Right upper lobe collapse with the S sign of Golden secondary to underlying non–small cell carcinoma of the bronchus.

Non–small cell lung cancer. Comparative cha...
(Enlarge Image)
Media file 10: Non–small cell lung cancer. Comparative characteristics of the primary tumor are shown in the vertical columns. Horizontal columns refer to lymph node involvement. The different stages are color coded and can be found at the intersection of appropriately matched horizontal and vertical columns. Stages with unique characteristics, such as stages 0 and IV, are defined in separate boxes. Courtesy of Lababede et al (Chest 1999; 115(1): 233-5).
[ CLOSE WINDOW ]
Non–small cell lung cancer. Comparative cha...

Non–small cell lung cancer. Comparative characteristics of the primary tumor are shown in the vertical columns. Horizontal columns refer to lymph node involvement. The different stages are color coded and can be found at the intersection of appropriately matched horizontal and vertical columns. Stages with unique characteristics, such as stages 0 and IV, are defined in separate boxes. Courtesy of Lababede et al (Chest 1999; 115(1): 233-5).

More on Lung Cancer, Non-Small Cell

Overview: Lung Cancer, Non-Small Cell
Imaging: Lung Cancer, Non-Small Cell
Follow-up: Lung Cancer, Non-Small Cell
Multimedia: Lung Cancer, Non-Small Cell
References
Further Reading
[ CLOSE WINDOW ]

References

  1. Ravaioli A, Papi M, Pasquini E, Marangolo M, Rudnas B, Fantini M, et al. Lipoplatin monotherapy: A phase II trial of second-line treatment of metastatic non-small-cell lung cancer. J Chemother. Feb 2009;21(1):86-90. [Medline].

  2. Ohba T, Yamasaki T, Endo Y, Furuie M, Ohtani Y, Inase N, et al. A phase I study of TS-1 plus carboplatin in patients with advanced non-small-cell lung cancer. J Chemother. Feb 2009;21(1):80-5. [Medline].

  3. Ricciardi S, Tomao S, de Marinis F. Toxicity of targeted therapy in non-small-cell lung cancer management. Clin Lung Cancer. Jan 2009;10(1):28-35. [Medline].

  4. Herbst RS, Lynch TJ, Sandler AB. Beyond doublet chemotherapy for advanced non-small-cell lung cancer: combination of targeted agents with first-line chemotherapy. Clin Lung Cancer. Jan 2009;10(1):20-7. [Medline].

  5. Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg. Jan 1995;109(1):120-9. [Medline].

  6. [Best Evidence] Reck M, von Pawel J, Zatloukal P, Ramlau R, Gorbounova V, Hirsh V, et al. Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil. J Clin Oncol. Mar 10 2009;27(8):1227-34. [Medline].

  7. [Best Evidence] Fidias PM, Dakhil SR, Lyss AP, Loesch DM, Waterhouse DM, Bromund JL, et al. Phase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer. J Clin Oncol. Feb 1 2009;27(4):591-8. [Medline].

  8. [Best Evidence] Hanna N, Neubauer M, Yiannoutsos C, McGarry R, Arseneau J, Ansari R, et al. Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology. J Clin Oncol. Dec 10 2008;26(35):5755-60. [Medline].

  9. Lung Cancer Initiatives. Centers for Disease Control and Prevention. Department of Health and Human Services. Available at http://www.cdc.gov/cancer/lung/pdf/0809_lung_fs.pdf. Accessed May 30, 2009.

  10. US Cancer Statistics Working Group. United States Cancer Statistics: 1999–2005 Incidence and Mortality Web-based Report. Atlanta (GA). Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2009. Available at http://www.cdc.gov/uscs. Accessed May 30, 2009.

  11. Detailed Guide: Lung Cancer - Non-Small Cell What Are the Key Statistics About Lung Cancer?. American Cancer Society. Available at http://www.cancer.org/docroot/CRI/content/CRI_2_4_1x_What_Are_the_Key_Statistics_About_Lung_Cancer_15.asp?sitearea=. Accessed May 30, 2009.

  12. Hsu LH, Chu NM, Liu CC, Tsai SY, You DL, Ko JS, et al. Sex-associated differences in non-small cell lung cancer in the new era: Is gender an independent prognostic factor?. Lung Cancer. Mar 17 2009;[Medline].

  13. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, et al. SEER Cancer Statistics Review, 1975–2005, National Cancer Institute. Bethesda, MD, based on November 2007 SEER data submission, posted to the SEER Web site, 2008. SEER Web Site. Available at http://seer.cancer.gov/csr/1975_2005/. Accessed May 30, 2009.

  14. Miller WT. Value of clinical history. AJR Am J Roentgenol. Sep 1990;155(3):653-4. [Medline].

  15. Swensen SJ, Brown LR, Colby TV. Lung nodule enhancement at CT: prospective findings. Radiology. Nov 1996;201(2):447-55. [Medline].

  16. Hellwig D, Baum RP, Kirsch C. FDG-PET, PET/CT and conventional nuclear medicine procedures in the evaluation of lung cancer: A systematic review. Nuklearmedizin. Jan 14 2009;48(1):[Medline].

  17. ATS and ERS. Pretreatment evaluation of non-small-cell lung cancer. The American Thoracic Society and The European Respiratory Society. Am J Respir Crit Care Med. Jul 1997;156(1):320-32. [Medline].

  18. Botta DM, Head HD. Non-small cell lung cancer: an update. Curr Surg. Sep-Oct 2003;60(5):492-8. [Medline].

  19. Boulikas T, Vougiouka M. Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs (Review). Oncol Rep. Mar 2004;11(3):559-95. [Medline].

  20. Dales RE, Stark RM, Raman S. Computed tomography to stage lung cancer. Approaching a controversy using meta-analysis. Am Rev Respir Dis. May 1990;141(5 Pt 1):1096-101. [Medline].

  21. Hatter J, Kohman LJ, Mosca RS, et al. Preoperative evaluation of stage I and stage II non-small cell lung cancer. Ann Thorac Surg. Dec 1994;58(6):1738-41. [Medline].

  22. Henschke CI, Naidich DP, Yankelevitz DF, et al. Early lung cancer action project: initial findings on repeat screenings. Cancer. Jul 1 2001;92(1):153-9. [Medline].

  23. Hillers TK, Sauve MD, Guyatt GH. Analysis of published studies on the detection of extrathoracic metastases in patients presumed to have operable non-small cell lung cancer. Thorax. Jan 1994;49(1):14-9. [Medline].

  24. Lababede O, Meziane MA, Rice TW. TNM staging of lung cancer: a quick reference chart. Chest. Jan 1999;115(1):233-5. [Medline].

  25. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin. Jan-Feb 1999;49(1):8-31, 1. [Medline].

  26. Lowe VJ, Naunheim KS. Positron emission tomography in lung cancer. Ann Thorac Surg. Jun 1998;65(6):1821-9. [Medline].

  27. Mac Manus MP, Hicks RJ, Ball DL, et al. F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment. Cancer. Aug 15 2001;92(4):886-95. [Medline].

  28. McLoud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology. Feb 1992;182(2):319-23. [Medline].

  29. Michel F, Soler M, Imhof E, Perruchoud AP. Initial staging of non-small cell lung cancer: value of routine radioisotope bone scanning. Thorax. Jul 1991;46(7):469-73. [Medline].

  30. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest. Jun 1997;111(6):1710-7. [Medline].

  31. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. Jun 19 1993;54(4):594-606. [Medline].

  32. Patz EF Jr, Erasmus JJ, McAdams HP, et al. Lung cancer staging and management: comparison of contrast-enhanced and nonenhanced helical CT of the thorax. Radiology. Jul 1999;212(1):56-60. [Medline].

  33. Reilly JJ. Preparing for pulmonary resection: preoperative evaluation of patients. Chest. Oct 1997;112(4 Suppl):206S-208S. [Medline].

  34. Roberts JR, Blum MG, Arildsen R, et al. Prospective comparison of radiologic, thoracoscopic, and pathologic staging in patients with early non-small cell lung cancer. Ann Thorac Surg. Oct 1999;68(4):1154-8. [Medline].

  35. Scott WJ, Shepherd J, Gambhir SS. Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis. Ann Thorac Surg. Dec 1998;66(6):1876-83; discussion 1883-5. [Medline].

  36. Shaffer K. Radiologic evaluation in lung cancer: diagnosis and staging. Chest. Oct 1997;112(4 Suppl):235S-238S. [Medline].

  37. Silvestri GA, Hoffman BJ, Bhutani MS, et al. Endoscopic ultrasound with fine-needle aspiration in the diagnosis and staging of lung cancer. Ann Thorac Surg. May 1996;61(5):1441-5; discussion 1445-6. [Medline].

  38. Travis WD, Lubin J, Ries L, Devesa S. United States lung carcinoma incidence trends: declining for most histologic types among males, increasing among females. Cancer. Jun 15 1996;77(12):2464-70. [Medline].

  39. Vansteenkiste JF, Stroobants SG. The role of positron emission tomography with 18F-fluoro-2-deoxy-D- glucose in respiratory oncology. Eur Respir J. Apr 2001;17(4):802-20. [Medline].

  40. White CS, Templeton PA, Belani CP. Imaging in lung cancer. Semin Oncol. Apr 1993;20(2):142-52. [Medline].

[ CLOSE WINDOW ]

Further Reading

Clinical guidelines
Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non-small-cell lung cancer guideline. American Society of Clinical Oncology - Medical Specialty Society
Cancer Care Ontario - State/Local Government Agency [Non-U.S.]. 2007 Dec. 13 pages. NGC:006052

Postoperative adjuvant radiation therapy in stage II or IIIA completely resected non-small cell lung cancer.
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. 1997 Sep 15 (revised 2005 Feb). 16 pages. NGC:004124

Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines. (2nd Edition)
American College of Chest Physicians - Medical Specialty Society. 2003 Jan (revised 2007 Sep). 23 pages. NGC:005935

Clinical trials

 Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung Cancer

Gene-Expression Profiles in CNS-Metastatic Non-Small Cell Lung Cancer

Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC)


Related eMedicine topics
Lung Cancer, Small Cell

Lung Cancer, Staging

Lung, Carcinoid

Lung, Metastases

Pancoast Syndrome

[ CLOSE WINDOW ]

Keywords

lung cancer, bronchogenic carcinoma, primary lung malignancy, small cell lung cancer, SCLC, non–small cell lung cancer, non–small-cell lung cancer, NSCLC, lung carcinoma, lung tumor, asbestos, smoking

[ CLOSE WINDOW ]

Contributor Information and Disclosures

Author

Sat Sharma, MD, FRCPC, Professor and Head, Division of Pulmonary Medicine, Department of Internal Medicine, University of Manitoba; Site Director, Respiratory Medicine, St Boniface General Hospital
Sat Sharma, MD, FRCPC is a member of the following medical societies: American Academy of Sleep Medicine, American College of Chest Physicians, American College of Physicians-American Society of Internal Medicine, American Thoracic Society, Canadian Medical Association, Royal College of Physicians and Surgeons of Canada, Royal Society of Medicine, Society of Critical Care Medicine, and World Medical Association
Disclosure: Nothing to disclose.

Coauthor(s)

Bruce Maycher, MD, Director of Pulmonary Radiology, St Boniface General Hospital; Associate Professor, Department of Radiology, University of Manitoba
Bruce Maycher, MD is a member of the following medical societies: American Roentgen Ray Society, Canadian Medical Association, Radiological Society of North America, and Society of Thoracic Radiology
Disclosure: Nothing to disclose.

Medical Editor

Kitt Shaffer, MD, PhD, Director of Undergraduate Medical Education, Associate Professor, Department of Radiology, Cambridge Health Alliance
Kitt Shaffer, MD, PhD is a member of the following medical societies: American Roentgen Ray Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand
Disclosure: Nothing to disclose.

Managing Editor

W Richard Webb, MD, Professor, Department of Radiology, University of California at San Francisco
Disclosure: Nothing to disclose.

CME Editor

Robert M Krasny, MD, Resolution Imaging Medical Corporation
Robert M Krasny, MD is a member of the following medical societies: American Roentgen Ray Society and Radiological Society of North America
Disclosure: Nothing to disclose.

Chief Editor

Barry H Gross, MD, Professor, Department of Radiology, University of Michigan Medical School; Professor, University of Michigan Cancer Center
Barry H Gross, MD is a member of the following medical societies: American College of Chest Physicians, American College of Radiology, American Roentgen Ray Society, Association of University Radiologists, Michigan State Medical Society, Physicians for Social Responsibility, Radiological Society of North America, and Society of Thoracic Radiology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.